Dose-Dependent Microglial and Astrocytic Responses Associated With Post-ischemic Neuroprotection After Lipopolysaccharide-Induced Sepsis-Like State in Mice.
microglial activation
middle cerebral artery occlusion
morphological analysis
neuroprotection
reactive astrocyte
sepsis
Journal
Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935
Informations de publication
Date de publication:
2020
2020
Historique:
received:
23
09
2019
accepted:
29
01
2020
entrez:
3
3
2020
pubmed:
3
3
2020
medline:
3
3
2020
Statut:
epublish
Résumé
In contrast to lipopolysaccharide (LPS)-induced preconditioning, which has repeatedly been examined in the past, the effects of post-ischemic LPS-induced sepsis, although clinically considerably more important, have not systemically been studied. We exposed mice to transient intraluminal middle cerebral artery occlusion (MCAO) and examined the effects of intraperitoneal LPS (0.1 or 1 mg/kg) which was administered 24 h post-ischemia. Post-ischemic glial reactivity, neuronal survival and neurological outcome were differently modulated by the higher and the lower LPS dose. Although both doses promoted neuronal survival after 72 h, the underlying mechanisms were not similar. Mice receiving 1 mg/kg LPS exhibited transient hypothermia at 1 and 3 hours post sepsis (hps), followed by reduced focal neurological deficits at 24, 48 and 72 hps. The lower dose (0.1 mg/kg) did not induce hypothermia, but reduced microglia/macrophage activation with the appearance of an anti-inflammatory CD206 positive cell phenotype in the brain parenchyma. Together, our results indicate a novel, dose-dependent modulation of microglial cells that is intricately involved in brain protection.
Identifiants
pubmed: 32116567
doi: 10.3389/fncel.2020.00026
pmc: PMC7029732
doi:
Types de publication
Journal Article
Langues
eng
Pagination
26Informations de copyright
Copyright © 2020 Sardari, Dzyubenko, Schmermund, Yin, Qi, Kleinschnitz and Hermann.
Références
Eur J Neurosci. 2005 Nov;22(10):2441-50
pubmed: 16307587
Stroke. 2018 Oct;49(10):2495-2503
pubmed: 30355106
Front Cell Neurosci. 2016 Aug 05;10:196
pubmed: 27547178
Lancet Neurol. 2012 Apr;11(4):369-80
pubmed: 22441198
Stroke. 2004 Nov;35(11):2576-81
pubmed: 15375302
J Neuroinflammation. 2011 Oct 14;8:140
pubmed: 21999375
J Cereb Blood Flow Metab. 2003 Apr;23(4):399-405
pubmed: 12679716
Nature. 2016 Apr 14;532(7598):195-200
pubmed: 27027288
Glia. 2005 Oct;52(1):78-84
pubmed: 15920727
J Clin Invest. 2012 Apr;122(4):1164-71
pubmed: 22466658
Brain Res. 1996 Jul 8;726(1-2):160-6
pubmed: 8836556
Cell. 2019 Jan 24;176(3):581-596.e18
pubmed: 30661753
J Neurosci. 2002 May 15;22(10):3921-8
pubmed: 12019311
Brain Res Bull. 2011 Jul 15;85(6):403-9
pubmed: 21571046
Mol Med Rep. 2018 Jan;17(1):1599-1608
pubmed: 29257197
Neurol Res. 1997 Dec;19(6):641-8
pubmed: 9427967
Neuroscience. 2013 Jun 3;239:92-102
pubmed: 23079632
Science. 2018 Mar 16;359(6381):1269-1273
pubmed: 29420261
Prog Neurobiol. 2017 Oct;157:247-272
pubmed: 26851161
Prostaglandins Leukot Essent Fatty Acids. 1993 Dec;49(6):955-8
pubmed: 8140123
Int J Mol Sci. 2019 May 09;20(9):
pubmed: 31075861
Nature. 2018 May;557(7707):724-728
pubmed: 29769726